Clinical Trial Update: Bosentan in Systemic Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating bosentan for systemic sclerosis with digital ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digital Ulcers
• Systemic Sclerosis

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Actelion | Conditions: Systemic Sclerosis, Digital Ulcers | Phase 4 | Status: COMPLETED